RITPBC: B-CELL DEPLETING THERAPY (RITUXIMAB) AS A TREATMENT FOR FATIGUE IN PRIMARY BILIARY CIRRHOSIS: STUDY PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL

被引：0
|
作者：
Jopson, L.
Newton, J. L. [1 ]
Howel, D. [2 ]
Palmer, J. [3 ]
Isaacs, J. [3 ]
Qian, J. [4 ]
Wilkinson, J. [4 ]
Blamire, A. [3 ]
Floudas, A. [3 ]
Jones, D. E. [3 ]
机构：
[1] Newcastle Univ, Inst Hlth & Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[4] Newcastle Univ, Newcastle Clin Trials Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1328
引用
收藏
页码：S853 / S854
页数：2
相关论文
共 50 条
  • [1] RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial
    Jopson, Laura
    Newton, Julia L.
    Palmer, Jeremy
    Floudas, Achilleas
    Isaacs, John
    Qian, Jessica
    Wilkinson, Jennifer
    Trenell, Mike
    Blamire, Andrew
    Howel, Denise
    Jones, David E.
    BMJ OPEN, 2015, 5 (08):
  • [2] B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cholangitis: a randomised controlled trial (RITPBC)
    Jopson, L.
    Khanna, A.
    Blamire, A.
    Newton, J.
    Palmer, J.
    Bryant, A.
    Howel, D.
    Steel, A.
    Wilkinson, J.
    Jones, D.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S96 - S96
  • [3] Effects of B-Cell depleting therapy (Rituximab) on liver biochemistry in UDCA-responsive patients: results from a randomised controlled trial of Rituximab in fatigued PBC patients (RitPBC).
    Khanna, Amardeep
    Jopson, Laura
    Blamire, Andrew M.
    Newton, Julia L.
    Howel, Denise
    Bryant, Andrew
    Wilkinson, Jennifer
    Steel, Alison
    Jones, David
    HEPATOLOGY, 2017, 66 : 43A - 43A
  • [4] B-Cell Depletion With Rituximab in Patients With Primary Biliary Cirrhosis Refractory to Ursodeoxycholic Acid
    Myers, Robert P.
    Swain, Mark G.
    Lee, Samuel S.
    Shaheen, Abdel Aziz M.
    Burak, Kelly W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (06): : 933 - 941
  • [5] B-cell controlled therapy with rituximab
    Limmroth, Volker
    Bernsen, Sarah
    Haas, Judith
    Schwab, Stafan
    Amini, Cyrus
    Hartung, Hans-Peter
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 681 - 681
  • [6] Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634]
    ter Borg, PCJ
    van Os, E
    van den Broek, WW
    Hansen, BE
    van Buuren, HR
    BMC GASTROENTEROLOGY, 2004, 4 (1)
  • [7] Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634]
    Pieter CJ ter Borg
    Erik van Os
    Walter W van den Broek
    Bettina E Hansen
    Henk R van Buuren
    BMC Gastroenterology, 4
  • [8] A placebo controlled randomised crossover trial of oral antioxidant supplementation for fatigue in primary biliary cirrhosis (PBC).
    Prince, M
    Mitchison, HC
    Ashley, D
    Burke, DA
    Edwards, M
    Bramble, MG
    James, OF
    Jones, DE
    HEPATOLOGY, 2002, 36 (04) : 417A - 417A
  • [9] A placebo controlled randomised crossover trial of oral antioxidant supplementation for fatigue in primary biliary cirrhosis (PBC)
    Prince, MI
    Mitchison, HC
    Ashleigh, D
    Burke, D
    Edwards, M
    Bramble, MG
    James, OFW
    Jones, DEJ
    GUT, 2003, 52 (05)
  • [10] Rituximab Is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase 2 Randomized Controlled Trial
    Khanna, Amardeep
    Jopson, Laura
    Howel, Denise
    Bryant, Andrew
    Blamire, Andrew
    Newton, Julia L.
    Jones, David E.
    HEPATOLOGY, 2019, 70 (05) : 1646 - 1657
12345